Two Sigma Securities’s Array Biopharma Inc ARRY Stock Holding History

Two Sigma Securities’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-19,017	Closed	-$159K	–	1337
2017 Q2	$159K	Sell	19,017 -8,919	-32%	-$72.9K	0.03%	604
2017 Q1	$250K	Buy	+27,936	New	+$297K	0.05%	478

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Two Sigma Securities's ARRY Position: Q3 2017 in Review

Two Sigma Securities sold out of Array Biopharma Inc (ARRY) in Q3 2017, closing a stake of 19,017 shares — an estimated $159K sold.

Two Sigma Securities first reported a position in ARRY in Q1 2017 and held it in 2 quarters. The position peaked at $250K in Q1 2017. 184 funds tracked by Wall St. Rank hold ARRY as of Q3 2017.

Two Sigma Securities reported no remaining Array Biopharma Inc position as of Q3 2017 after selling out during the quarter.
Two Sigma Securities sold 19,017 Array Biopharma Inc shares in Q3 2017, an estimated $159K.
Two Sigma Securities first reported a position in Array Biopharma Inc in Q1 2017 and held it in 2 quarters.
Two Sigma Securities's Array Biopharma Inc position peaked at $250K in Q1 2017.
184 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2017.

Based on Two Sigma Securities's 13F filing for Q3 2017, filed 14 Nov 2017.